Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein

British Journal of Cancer

Volumn 103, Issue 11, 2010, Pages 1649-1656

  Jagdev, S P K ^a   Gregory, W ^b   Vasudev, N S ^a   Harnden, P ^a   Sim, S ^a   Thompson, D ^a   Cartledge, J ^a   Selby, P J ^a   Banks, R E ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

CRP; nomogram; pre operative; prognosis; RCC

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LEUKOCYTE COUNT; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; NEUTROPHIL; OVERALL SURVIVAL; PREDICTION; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 78650181422     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605973     Document Type: Article

References (30)

1. Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27: 2217-2224
2. Bukowski RM (2009) Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. Cancer 115(10 Suppl): 2273-2281
3. Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, Lee K (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immun-other 58: 15-23
4. Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED (2008) Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer 113: 450-460
5. Galfano A, Novara G, Iafrate M, Cavalleri S, Martignoni G, Gardiman M, D'Elia C, Patard JJ, Artibani W, Ficarra V (2008) Mathematical models for prognostic prediction in patients with renal cell carcinoma. Urol Int 80: 113-123
6. George S, Bukowski RM (2007) Biomarkers in clear cell renal cell carcinoma. Expert Rev Anticancer Ther 7: 1737-1747
7. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247: 2543-2546
8. Heikkila K, Ebrahim S, Lawlor DA (2007) A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61: 824-832
9. Heikkila K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, Ben-Shlomo Y, Ebrahim S, Lawlor DA (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20: 15-26
10. Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K (2009) Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on pre-operative serum C-reactive protein and TNM classification: the TNM-C score. J Urol 181: 1004-1012
11. Ito K, Asano T, Yoshii H, Satoh A, Sumitomo M, Hayakawa M (2006) Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma. Int J Urol 13: 1365-1370
12. Jabs WJ, Busse M, Kruger S, Jocham D, Steinhoff J, Doehn C (2005) Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int 68: 2103-2110
13. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J (2003) The kidney is a second site of human C-reactive protein formation in vivo. Eur J Immunol 33: 152-161
14. Karakiewicz PI, Hutterer GC, Trinh QD, Jeldres C, Perrotte P, Gallina A, Tostain J, Patard JJ (2007) C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 110: 1241-1247
15. Karakiewicz PI, Suardi N, Capitanio U, Jeldres C, Ficarra V, Cindolo L, De La Taille A, Tostain J, Mulders PFA, Bensalah K, Artibani W, Salomon L, Zigeuner R, Valeri A, Descotes J-L, Rambeaud J-J, Mejean A, Montorsi F, Bertini R, Patard J-J (2009) A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Uro 55: 287-295
16. Kawata N, Nagane Y, Yamaguchi K, Ichinose T, Hirakata H, Takahashi S (2008) How do symptoms have an impact on the prognosis of renal cell carcinoma. Int J Urol 15: 299-303
17. Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Figlin RA, Horvath S, Belldegrun AS (2004) Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 10(16): 5464-5471
18. Klatte T, Seligson DB, LaRochelle J, Shuch B, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Pantuck AJ, Belldegrun AS (2009) Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev 18: 894-900
19. Komai Y, Saito K, Sakai K, Morimoto S (2007) Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. BJU Int 99: 77-80
20. Lamb GWA, McArdle PA, Ramsey S, McNichol A-M, Edwards J, Aitchison M, McMillan DC (2008) The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. Br J Urol 102: 756-762
21. Lane BR, Kattan MW (2008) Prognostic models and algorithms in renal cell carcinoma. Urol Clin North Am 35: 613-625
22. Ledue TB, Rifai N (2003) Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 49: 1258-1271
23. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97(16): 1180-1184
24. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511
25. Ramsey S, Lamb GWA, Aitchison M, McMillan DC (2008) Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. Br J Urol 101: 959-963
26. Rouviere O, Bouvier R, Negrier S, Badet L, Lyonnet D (2006) Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up? Nat Clin Pract Oncol 3(4): 200-213
27. Ruckerl R, Peters A, Khuseyinova N, Andreani M, Koenig W, Meisinger C, Dimakopoulou K, Sunyer J, Lanki T, Nyberg F, Schneider A (2009) Determinants of the acute-phase response protein C-reactive protein in myocardial infarction survivors: the role of co-morbidities and environmental factors. Clin Chem 55: 322-335
28. Schemper M, Henderson R (2000) Predictive accuracy and explained variation in Cox regression. Biometrics 56: 249-255
29. Vasudev NS, Brown JE, Brown SR, Rafiq R, Morgan R, Patel PM, O'Donnell D, Harnden P, Rogers M, Cocks K, Anderson K, Paul A, Eardley I, Selby PJ, Banks RE (2008) Prognostic factors in renal cell carcinoma: asopciation of preoperative sodium concentration with survival. Clin Cancer Res 14: 1775-1781
30. Vasudev NS, Sim S, Cairns DA, Feguson RE, Craven RA, Stanley A, Cartledge J, Thompson D, Selby PJ, Banks RE (2009) Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma. Br J Cancer 101: 1175-1182